✦ LIBER ✦

Clinical implications of HER-2/neu overexpression and proteolytic activity imbalance in breast cancer

✍ Scribed by Menha Swellam; Lobna R. Ezz El Arab; Hussein A. Bushnak

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Implication of polysomy 17 in HER-2/neu

✍ I. Vanden Bempt; De Wolf-Peeters; F. Amant; P. Neven; H. Wildiers; R. Paridaens; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 269 KB

EGFR activity in Her-2 overexpressing me

✍ D. Gschwantler-Kaulich; Hudelist; W.J. Koestler; K. Czerwenka; R. Mueller; E. Ru 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 135 KB

The tumor suppression activity of E1A in

✍ Chang, Joe Yujiao; Xia, Weiya; Shao, Ruping; Sorgi, Frank; Hortobagyi, Gabriel N 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 657 KB

Clinical Utility of Serum HER2/neu in Br

✍ G. Kesava Reddy; Vinay K. Jain; Kim Leitzel; Joyce A. O'Shaughnessy 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 99 KB

Aneusomy 17 in Breast Cancer: Its Role i

✍ Wang, Sijian; Saboorian, M. Hossein; Frenkel, Eugene P.; Haley, Barbara B.; Sidd 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 803 KB

S1960 Clinical Significance of HER2/Neu

✍ Barojas, Paola Figueroa; Alejandra, Zarate Osorno; Quiñonez-Urrego, Enoe E.; Her 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 70 KB